Mammography Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, UK, Germany, Japan - Size and Forecast 2024-2028

Mammography Market Forecast 2024-2028

The global mammography market size is estimated to grow by USD 1.41 billion, at a CAGR of 10.34% between 2023 and 2028. 

The increasing adoption of portable breast cancer screening devices is primarily driven by the growing emphasis on early detection, crucial for improving breast cancer treatment outcomes and reducing mortality rates. These portable mammography units facilitate screenings in remote or underserved areas and patients' homes, expanding access to screening programs. Advanced technology has enabled the development of compact and lightweight portable mammography systems, offering excellent imaging results and ease of use in non-traditional settings. Conducting bedside or outpatient mammograms enhances patient convenience, accelerates diagnosis, and enables prompt intervention and treatment, thereby improving screening and treatment effectiveness. For instance, Metaltronica offers a mobile mammography unit as part of the ROSA Project, supporting high-quality screening and diagnostics, and driving growth in the market.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Download Report Sample

Segmentation by End-user, Type, and Geography Analysis

End-user Analysis

The market share by the hospitals segment will be significant during the forecast period. Hospitals are primary healthcare providers and play an important role in breast cancer treatment. They serve a wide range of patients and provide a wide range of healthcare services, including mammography, to detect early abnormalities in the breast. The prevalence of breast cancer is on the rise across the world, driving the market for advanced mammography technologies and services within hospital settings. 

Get a glance at the market contribution of various segments Download PDF Sample

The hospitals segment was valued at USD 841.68 million in 2018. Additionally, the growth of the hospital segment of the market is further supported by awareness campaigns and government programs related to early screening and diagnostics for breast cancer and the use of AI in breast cancer screening. Hospitals adopt AI-based imaging interpretation and analysis solutions in mammography units, helping radiologists identify small abnormalities and enhance diagnostic accuracy. Furthermore, hospitals responded to the pandemic by implementing safety protocols and embracing telehealth for consultations. These factors under the hospital's segment will fuel market growth during the forecast period.

Type Analysis

Three-dimensional (3D) mammography, also referred to as digital breast tomosynthesis, is an advanced cutting-edge X-ray imaging technology used to screen for and diagnose breast cancer. In contrast to conventional mammography, which produces flat, 2D images, 3D mammography captures multiple images from varied angles and merges them to generate a three-dimensional view of breast tissue. FDA approval in 2011 established 3D mammography as the standard for breast cancer screening. Approximately 85% of US screening facilities now offer 3D mammograms. Leading vendors like Hologic, Inc. and Allengers Medical Systems Limited provide advanced 3D mammography systems, such as Hologic's Genius, enhancing diagnostic precision. Siemens Healthcare Private Limited's MAMMOMAT Revelation system further boosts the market by offering advanced 3D imaging capabilities, fueling global market growth.

Two-dimensional (2D) mammography constitutes a significant share of the market. 2D mammography, also known as digital mammography, employs X-rays to detect breast tissue abnormalities, serving as the conventional method for breast cancer screening. It captures two images of each breast from different angles, providing a 2D view. Market leaders like Analogic Corporation and Hologic, Inc. offer 2D mammography units. Analogic's flat-panel 2D digital mammography units utilize amorphous selenium technology for superior image quality, while Hologic's Selenium Dimensions system combines high-resolution imaging with advanced software for enhanced early detection of breast cancer. Hologic's innovative 2D mammography solutions have established a strong market presence, making it a preferred choice among healthcare providers worldwide and driving global market growth.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 34% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. In 2023, North America held a prominent and significant share in the market. The region includes the US, Canada and Mexico. Together, these countries contribute significantly to the development, innovation, and advancement of mammography technologies. North America's unique healthcare model, cutting-edge technology, and strong emphasis on women's health also contribute to the regional market.

Moreover, the developed countries in North America, such as the US and Canada, provide support for early diagnosis of breast cancer. The US government conducts the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) for low-income, uninsured, and unemployed women, which allows them to avail of timely breast and cervical cancer screening and diagnostic services. Thus, such factors will drive the demand for mammography during the forecast period.

Buy Full Report Now

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

• Allengers Medical Systems Ltd.: The company offers mammography systems such as Fairy DR Adv Fairy DRplus, Fairy DR 3D Fairy DR 3Dplus, Fairy, Venus DRV Venus DRVplus, and Venus.

Analogic Corp., BMI Biomedical International s.r.l., Canon Inc., Carestream Health Inc., Dilon Technologies Inc., GE Healthcare Technologies Inc., General Medical Merate Spa, GENORAY Co. Ltd., Hologic Inc., IMS Giotto S.p.A., Konica Minolta Inc., Koninklijke Philips N.V., Metaltronica Spa, PerkinElmer Inc, Planmed Oy, Shanghai United Imaging Healthcare Co. Ltd., Siemens Healthineers AG, Sumitomo Mitsui Financial Group., and NP JSC AmicoA

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamics and Customer Landscape

The market plays a critical role in the early detection and diagnosis of breast cancer, a leading cause of cancer-related deaths worldwide. With initiatives by organizations like the American Cancer Society and Kao Group, governments and healthcare organizations are driving awareness campaigns to encourage regular screenings, particularly among demographics like Japanese females. Reimbursement policies and healthcare expenditures support the adoption of advanced medical technology, including mammography, aided by FDA approvals and artificial intelligence (AI) integration. Radiologists rely on various mammography types, from traditional 2-D and 3-D technologies to advanced combination technology, available through digital and analog systems. These services are offered across hospitals, specialty clinics, research institutes, and diagnostic centers, manned by skilled healthcare professionals adept in breast tomosynthesis and film screen systems. Our researchers analyzed the market research and growth data with 2023  as the base year, along with the key market growth analysis, trends, and challenges. A holistic analysis of drivers, trends, and challenges will help companies refine their marketing strategies to gain a competitive advantage. 

Key Drivers

Increasing focus on early examination and diagnosis of breast cancer is the key factor driving the market. AI algorithms can analyze a mammogram with greater accuracy than people can, helping detect abnormalities earlier and reducing the risk of false negative or false positive results. This is especially important in the field of breast cancer, where early detection is critical to improving patient outcomes. A number of key market players have acknowledged the disruptive effect of AI on the field of mammography and incorporated 2-D Technology and 3-D Technology in their imaging solutions.

For example, Hologic, Inc., another key market player provides the Hologic 3D Genius AI Detection Solution, which offers enhanced and superior quality mammography screening through accurate spotting, faster triaging tools, and prioritizing suspicious lesions, thereby assisting radiologists in their decision-making process. Further, the use of AI in mammography is also increasing due to the growing focus on personalized medicine and the need for more personalized and accurate diagnostic methods. Thus, such factors will foster the growth of the market during the forecast period. Additionally, advancements in medical technology and computer programming have contributed to the integration of AI in mammography, enabling better detection and diagnosis in hospitals, specialty clinics, research institutes, and diagnostic centers.

Significant Trends

Growing focus on courses and medical exhibitions for breast imaging products is one of the primary market trends. Treatment of any medical condition can be recommended based on its proper diagnosis and on the efficacy of the treatment for the same. Making people aware of the importance of diagnoses and imaging to identify a medical condition or disease is important. Hence, WORLD CLASS CME, a physician-founded company, is focusing on providing medical education in the areas of radiology, ultrasound, gynecology, and sleep medicine. The objective of this course is to make the target audience understand the anatomic and histopathologic basis for ultrasound appearances, the appropriate selection of ultrasound equipment for better diagnosis, and the correct classification of small invasive breast cancers while minimizing false-positive ultrasound examinations, among others.

Additionally, the Radiological Society of North America, a non-profit organization, organized the 105^th Scientific Assembly and Annual Meeting, which was held on December 1-6, 2019, at McCormick Place in Chicago, US. At this scientific radiology conference, companies introduced new and innovative medical imaging products, including those used in mammography, and showcased them to the attendees. Such global conferences comprise a large number of professional attendees from different countries, and therefore, they increase the reach of any company's product and help the company establish its position in the market. These factors will boost market growth during the forecast period.

Major Challenges

The risk of adverse effects from radiation is a challenge that affects market expansion. While the X-ray dosages used in breast cancer screening are very low, repeated exposures over a long period of time can cause a build-up of radiation doses. As a result, there has been a lot of discussion in the medical community about how to weigh the advantages of early breast cancer detection against the risks of radiation exposure. The radiation dose from a 3D mammogram may be slightly lower or slightly higher than that from a standard 2D mammogram.

Moreover, key market players like GE Healthcare and Hologic, Inc. are also investing in cutting-edge solutions, like low-dose systems, to reduce the risk of radiation exposure while preserving the diagnostic efficacy of the equipment. However, early breast cancer detection has been proven to improve survival rates and treatment results for patients, and the fear of radiation has resulted in less adherence to screening recommendations. Thus, such factors will hinder market expansion during the forecast period.

Buy Now Full Report

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market growth and forecasting report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

 Customer Landscape

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028. 

• End-user Outlook
  • Hospitals
  • Diagnostic centers

• Type Outlook
  • 3D
  • 2D
  • Analog

• Region Outlook
  • North America
    • The U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • Rest of World (ROW)
    • Brazil
    • Argentina
    • Australia

Market Analyst Overview:

The market is witnessing significant advancements driven by collaborations between healthcare organizations and medical technology firms. With rising awareness campaigns such as the Pink Ribbon Campaign and initiatives by the American Cancer Society, focus on early detection among breast cancer patients has intensified. Adoption of artificial intelligence (AI) in medical image interpretation has enhanced accuracy, with AI technologies like Transpara and Fusion AI leading the forefront. Modern mammography technology, including digital systems and breast tomosynthesis technology, offers superior diagnostic capabilities. With support from government reimbursement policies and technological innovations, the market is poised for robust growth, catering to healthcare professionals and patient advocacy groups alike.

Further, the market is influenced by various factors, including governments setting healthcare policies and budgets. Companies like FUJIFILM Medical Systems U.S.A., Inc. are pivotal in developing advanced mammography products such as Harmony and Amulet Innovality, catering to Japanese females and geriatric populations. With rising healthcare expenditure and disposable incomes, demand for digital mammography technology and 3D systems is escalating. ScreenPoint Medical leads in AI-driven solutions like Transpara, enhancing screening mammography end-user accuracy. Specialty clinics and research institutes play vital roles in cancer screening programs and clinical trials, ensuring continuous advancements in mammography technology for improved patient care.

Furthermore, the market is shaped by key players like the Kao Group, driving advancements in mammography technology through computer programming and innovative combination technology. Both diagnostic mammography type and full field digital mammography (FFDM) are crucial components utilized by skilled healthcare professionals in diagnostic centers worldwide, including BreastScreen Australia and the U.S. mammography market. Esteemed publications like the Journal of the American College of Radiology and Lancet Oncology contribute to industry insights. Regulatory bodies like the American College of Radiology (ACR) and World Health Organization (WHO) ensure quality standards, while organizations like the Health Resources and Services Administration (HRSA) and Goa government drive regional initiatives. Competitive benchmarking and technology insights drive strategic decisions for radiology centers and breast imaging specialists aiming to optimize company revenue shares, company insights and seize regional opportunities.

Market Scope
Report Coverage	Details
Page number	164
Base year	2023
Historic period	2018 - 2022
Forecast period	2024-2028
Growth momentum & CAGR	Accelerate at a CAGR of 10.34%
Market growth 2024-2028	USD 1412.98 million
Market structure	Fragmented
YoY growth 2023-2024(%)	10.2
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 34%
Key countries	US, Canada, UK, Germany, and Japan
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	Allengers Medical Systems Ltd., Analogic Corp., BMI Biomedical International s.r.l., Canon Inc., Carestream Health Inc., Dilon Technologies Inc., GE Healthcare Technologies Inc., General Medical Merate Spa, GENORAY Co. Ltd., Hologic Inc., IMS Giotto S.p.A., Konica Minolta Inc., Koninklijke Philips N.V., Metaltronica Spa, PerkinElmer Inc, Planmed Oy, Shanghai United Imaging Healthcare Co. Ltd., Siemens Healthineers AG, Sumitomo Mitsui Financial Group., and NP JSC AmicoA
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the between 2024 and 2028
• Precise estimation of the size of the size and its contribution n of the market in focus to the parent market
• Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
• Companies landscape comparing criticality of inputs and factors of differentiation
• Exclusive Matrix on companies position and classification
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch